Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer

por Eggington, S, Tappenden, P, Pandor, A, Paisley, S, Saunders, M, Seymour, M, Sutcliffe, P, Chilcott, J
Publicado 2006

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoid...

por Sharp, L, Tilson, L, Whyte, S, O'Ceilleachair, A, Walsh, C, Usher, C, Tappenden, P, Chilcott, J, Staines, A, Barry, M, Comber, H
Publicado 2012

Reply: cost-effectiveness of population-based screening for colorectal cancer

por Sharp, L, Walsh, C, Whyte, S, Tilson, L, O'Ceilleachair, A, Usher, C, Tappenden, P, Chilcott, J, Staines, A, Barry, M, Comber, H
Publicado 2013